跳至主要内容
临床试验/NCT06118190
NCT06118190已完成不适用

The Effectiveness of Mesotherapy (Lidocaine and Proxicam) in the Treatment of Chronic Migraine

Kanuni Sultan Suleyman Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2019年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
27
试验地点
1
主要终点
Visual Analog Scale (VAS)

研究概览

简要总结

Mesotherapy is a type of injection frequently used in clinics. It is a treatment procedure that involves the injection of some drugs under the skin or into the skin. Mesotherapy is used in musculoskeletal system diseases, but it is reported that the effects of its use in migraine are uncertain.

详细描述

Migraine is one of the types of headaches. For the diagnosis of chronic migraine, the headache must last more than 15 days. Nerve blocks, oral medication and neuromodulation are recommended for migraine treatment.Mesotherapy is a type of injection frequently used in clinics. It is a treatment procedure that involves the injection of some drugs under the skin or into the skin. Mesotherapy is used in musculoskeletal system diseases, but it is reported that the effects of its use in migraine are uncertain. This study was planned to show the effectiveness of mesotherapy in patients with migraine.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

open label

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of chronic migraine disease

排除标准

  • Infection disease
  • Thyroid disease
  • Anemia disease
  • Systemic disease

研究组 & 干预措施

mesotherapy

Experimental

All participants who received mesotherapy were monitored regularly for the following three months to assess their prognosis and ensure patient adherence to treatment.

干预措施: Lidocain (Drug)

结局指标

主要结局

Visual Analog Scale (VAS)

时间窗: 12 th week

VAS rates pain on a scale of zero to 10. It is explained to the participant that 10 points means unbearable pain, zero points means no pain, and the patient is asked to rate his pain between zero and ten. Higher scores indicate increased pain severity

The frequency of painful days per month

时间窗: 12th week

The participant is asked how many days she/he feels pain in a month.Higher numbers indicate increased frequency of painful days

次要结局

  • Duration of attack per month(12th week)
  • the number of analgesic per month(12th week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elif Ozyigit

Principal Investigator

Kanuni Sultan Suleyman Training and Research Hospital

研究点 (1)

Loading locations...

相似试验